Novo Nordisk to Pay Up to $2 Billion for Rights to Experimental Obesity and Diabetes Drug
Novo Nordisk agreed to pay up to $2 billion for the rights to a developmental weight-loss and obesity drug from Chinese ...
Novo Nordisk strikes $2 billion deal with a Chinese company making a GLP-1 drug
Novo Nordisk on Monday announced a $2 billion deal with a Chinese company making a drug in the same GLP-1 space where the ...
Nature12d
Top companies and drugs by sales in 2024
1a). Darzalex (daratumumab), an anti-CD38 monoclonal antibody (mAb) for multiple myeloma, continues to be the biggest single growth driver for the company. AbbVie held on to the number two spot ...
FDA approves new drug to treat protein buildup in the heart
The FDA has approved a new drug for a serious heart condition that affects thousands of people. The drug, called Amvuttra ...
Sale of Ozempic Knockoffs Is Supposed to End Soon. Telehealth Companies Aren’t Happy.
Pharmaceutical giants are squaring off against telehealth companies and pharmacies selling custom-made versions of the hot ...
Why cheaper alternatives to weight-loss drugs like Wegovy, Zepbound will be tougher to get
The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...
Health benefits company co-founded by Dr. Oz could be a conflict of interest
Trump’s nominee to lead the Centers for Medicare and Medicaid Services is entangled in another potential conflict of interest ...
This startup is using AI to give failed drugs a second chance. Check out the pitch deck it used to attract investors.
Ignota Labs is using AI to fix failed drugs and bring them to market. It raised $6.9 million from investors with this pitch ...
STAT4d
Pharmalittle: We’re reading about copycat weight loss drugs, ADHD prescriptions spiking, and more
The FDA wants to end bulk production of copycat versions of weight loss drugs; telehealth companies and compounding ...